Vivakor board approve dividend for Regeneca International

NewsGuard 100/100 Score

Vivakor, Inc. (OTCBB:VIVK) announced today that its Board of Directors approved a dividend of shares of common stock of Regeneca International, Inc. ("Regeneca"). Vivakor previously received the shares from Regeneca in the fourth quarter of 2009 under a license agreement whereby Vivakor exclusively licensed to Regeneca, for the direct to consumer market, distribution rights to RegeneBlend, one of the new cutting-edge nutraceutical formulations developed by Vivakor. Under the license terms, Regeneca committed to purchase from Vivakor a minimum of $5 million in product over the initial three year license term and Vivakor will be the exclusive supplier to Regeneca. The interest currently held by Vivakor represents approximately 14% of Regeneca's outstanding shares and 100% of this interest will be distributed to Vivakor shareholders in the dividend. It is estimated that each Vivakor shareholder will be entitled to receive one share of Regeneca common stock for approximately every 11 shares of Vivakor common stock beneficially owned on the record date. The record date for the distribution is expected to be April 22, 2009, subject to FINRA and creditor approval, and the distribution date is expected to be April 30, 2010. After the dividend distribution, Vivakor will no longer have an ownership interest in Regeneca; however, it will continue to supply product to Regeneca under the terms of the license agreement.

Vivakor shareholders will not be required to take any action to receive the Regeneca common shares on the distribution date. 

Vivakor Chairman Matt Nicosia commented on the Board's decision, "Regeneca is already a tremendous partner of Vivakor. As the exclusive marketers of RegeneBlend in the direct to consumer market and the first group to market VivaBlend, they have more than demonstrated their value to us and to our shareholders. This dividend represents both Regeneca's and Vivakor's affirmation of the strategic plans of both companies. The dividend announcement and the growing revenue and collaboration opportunities for Vivakor all point to the strong efforts of Vivakor's management to create value for its shareholders." 

Regeneca President Larry Walter commented, "We are delighted to expand our shareholder base to include Vivakor's shareholders. This will broaden the awareness about our company and fits nicely with our plans to go public in the near future. In fact, we have already initiated that process. As we expand in the future, we plan on purchasing more products from Vivakor and expect to engage them to develop new technologies for the markets we serve."

Source:

 Vivakor, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
The impact of quinoa bioactive compounds on gut health